Clinical Trials Browser

Phase 2 × Tacrolimus × Tumor-Agnostic × Clear all

NCT01871441 2025-05-16

Haploidentical Donor Hematopoietic Stem Cell Transplant in Treating Patients With Hematologic Malignancies

Phase 2 Terminated

4 enrolled 10 charts

Neoplasms